Researchers also associate ending GLP-1 therapy before pregnancy with a few risks.* Women who stopped taking a GLP-1 RA before or during early pregnancy had roughly 1.3x the risk of preterm birth, gestational diabetes, and high blood pressure conditions during pregnancy, compared to similar women who had not taken a GLP-1 RA
Sugary foods and refined carbohydrates provide little nutritional value and can cause blood sugar spikes followed by fatigue
Key safety concerns include variable potency between batches, lack of sterility testing, unknown interactions with added ingredients, and potential contamination risks
Mounjaro EPAR Public Assessment Report
Table of Contents Recommended Injection Sites for Retatrutide Retatrutide is injected subcutaneously into the abdomen, front thigh, or outer upper arm, with the abdomen being the most accessible and commonly used site for self-administration
Heart, Kidney, and Blood Sugar: Where the Record Lives Semaglutides cardiovascular, kidney, blood-sugar, and weight evidence is attached to different doses and populations